Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX

Fifteen per cent of cancers maintain telomere length independently of telomerase by the homologous recombination (HR)-associated alternative lengthening of telomeres (ALT) pathway. A unifying feature of these tumours are mutations in ATRX. Here we show that expression of ectopic ATRX triggers a supp...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nat Commun
Auteurs principaux: Clynes, David, Jelinska, Clare, Xella, Barbara, Ayyub, Helena, Scott, Caroline, Mitson, Matthew, Taylor, Stephen, Higgs, Douglas R., Gibbons, Richard J.
Format: Artigo
Langue:Inglês
Publié: Nature Pub. Group 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4501375/
https://ncbi.nlm.nih.gov/pubmed/26143912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms8538
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires